This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Amgen Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Joseph Edward Shultz: Innovator in Protein Refolding Technology
Introduction
Joseph Edward Shultz is a notable inventor based in Santa Rosa Valley, California. He has made significant contributions to the field of biotechnology, particularly in the area of protein refolding. His innovative methods have the potential to enhance the efficiency of protein production in various applications.
Latest Patents
Joseph Edward Shultz holds a patent for a method titled "Refolding proteins using a chemically controlled redox state." This patent describes a technique for refolding proteins expressed in non-mammalian cells at concentrations of 2.0 g/L or higher. The method involves identifying the thiol pair ratio and the redox buffer strength to create optimal conditions for efficient folding. This approach can be applied over a range of volumes, including commercial scale, making it a valuable asset in the biotechnology industry.
Career Highlights
Shultz is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to further develop his expertise in protein engineering and contribute to groundbreaking research in the field.
Collaborations
Throughout his career, Joseph has collaborated with esteemed colleagues, including Roger Hart and Ronald Nixon Keener III. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Joseph Edward Shultz is a prominent figure in the biotechnology sector, recognized for his innovative methods in protein refolding. His contributions have the potential to significantly impact the efficiency of protein production, paving the way for advancements in various biotechnological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
